Lifestyle
Lifestyle trends and health tips
Golden Retriever Showdown Celebrates Love and Dedication in South Australia
The 13th Golden Retriever National in Tanunda showcases nearly 300 dogs, highlighting the passion of breeders and owners for this beloved breed.
Read analysis →
China and India: Lessons from Bamboo Growth Models in Economic Strategy
Explore how the foundational choices in education and health have shaped the economic trajectories of China and India in their post-colonial development.
Read analysis →New Mexico Court Orders Meta to Pay $806 Million for Youth Mental Health Violations
Meta faces an $806 million penalty in New Mexico for harming youth mental health through its platforms, with significant changes mandated for user safety.
Read analysis →Ugandan Boxers Go Missing After Commonwealth Games Raise Asylum Speculations
Four Ugandan boxers and a Pakistani athlete have reportedly gone missing after the Commonwealth Games, sparking speculation about potential asylum.
Read analysis →Pressure Mounts on NSW Government for Meaningful Mental Health Reforms Following Tragic Stabbing Incident
Advocates and victim's mother demand NSW government act decisively on mental health reforms after grim findings from the Bondi Junction inquest.
Read analysis →Luke Beveridge Would Have Signed Concussion Waiver to Extend Playing Career
Western Bulldogs coach Luke Beveridge expresses his willingness to sign a concussion waiver, highlighting the complex landscape of player safety in the AFL.
Read analysis →
Caspian Sea Faces Ecological Crisis Amidst Rising Water Withdrawals and Conflicting Demands
The Caspian Sea's declining water levels are driven by reduced river inflows and increased human water consumption, raising alarms about its ecological fate.
Read analysis →
Replimune's Melanoma Drug Receives FDA Approval After Previous Rejections
The FDA has approved Replimune's Tudriqev for advanced melanoma following prior rejections, underscoring urgent patient treatment needs.
Read analysis →
Medicare Policy Shift Grants AbbVie Drug Extended Price Negotiation Delay
A recent Medicare policy change delays price negotiations for an AbbVie drug by seven years, raising concerns about taxpayer costs as per a new analysis.
Read analysis →
U.S. Health Secretary Moves to Decertify Kentucky Organ Donation Group Over Safety Concerns
Health Secretary Robert F. Kennedy Jr. initiates decertification of Kentucky's Network for Hope amid allegations of serious safety lapses.
Read analysis →
FDA Advances mRNA Flu Vaccine and New Narcolepsy Treatment
Moderna's mRNA flu vaccine for older adults has received FDA approval, alongside a new narcolepsy treatment from Takeda, promising advancements in neurology.
Read analysis →
Medicare's ACCESS Initiative: Gaps in Provider Transparency
Despite the rollout of the ACCESS initiative, Medicare lacks clear guidance on available providers, leaving patients in the dark.
Read analysis →
Greg Verdine: A Biotech Executive's Success with LifeMine and Parabilis Medicines
Greg Verdine is realizing significant achievements in biotech with Parabilis and LifeMine, driving advancements in cancer treatment and organ transplants.
Read analysis →
Tenax Therapeutics Faces High Stakes with Upcoming Heart Failure Study Results
Tenax Therapeutics prepares for a pivotal Phase 3 study on a heart failure treatment, with potential implications for its market value.
Read analysis →
Evaluating AI's Impact on Healthcare: Current Insights and Uncertainties
A new study highlights that while AI tools in healthcare show promise, their effects on outcomes remain uncertain.
Read analysis →
Assessing the Current Status of Measles Elimination in the U.S.: A Critical Review
With rising measles cases in 2023, experts prepare to evaluate whether the U.S. still maintains its elimination status achieved in 2000.
Read analysis →
How a New Railway Project Could Alter Gulf Politics and Global Trade Dynamics
The Gulf Cooperation Council's ambitious railway project may reshape regional politics and trade, fostering greater integration and security in the Persian Gulf.
Read analysis →
Moderna's mRNA Influenza Vaccine Receives FDA Approval for Older Adults
The FDA has approved Moderna's mRNA flu vaccine for older adults, marking a significant milestone in vaccine technology.
Read analysis →
FDA Approves Takeda's Orzeyful: A New Era in Narcolepsy Treatment
Takeda's Orzeyful, a groundbreaking orexin receptor agonist, gains FDA approval, promising improved treatment options for narcolepsy patients.
Read analysis →
Federal Regulators Engage with Tech Leaders to Navigate Clinical AI Adoption
Federal health officials recently convened technology leaders to discuss the future of clinical AI, aiming to shape policies for its safe adoption.
Read analysis →